Annovis Bio Analyst Price Targets - Benzinga

Annovis Bio Inc

ANVSNYSE

Trade with Public

Trade with Public

$0.9900

-0.01-1%

最終更新: Oct 28, 9:29 AM

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

Annovis Bio Analyst Price Targets - Benzinga

Annovis Bio Analyst Price Targets

Wall Street analyst price targets and consensus rating for Annovis Bio (ANVS).

Price Target Range — 9 Quarters

Analyst Consensus — 8 Analysts

6Buy

2Hold

Consensus RatingBuy# Analysts8Avg. Consensus PT$28Upside to Avg. PT+2716.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 28, 2026	Roth Capital	Boobalan Pachaiyappan	PT Cut	Buy	$8→$7
Aug 18, 2026	Canaccord Genuity	Sumant Kulkarni	Maintained	Buy	$17
Jul 8, 2026	Roth Capital	Boobalan Pachaiyappan	Initiate	Buy	$8
Apr 14, 2026	Canaccord Genuity	Sumant Kulkarni	Maintained	Buy	$17
Sep 30, 2025	Canaccord Genuity	Sumant Kulkarni	Maintained	Buy	$17
Sep 3, 2025	HC Wainwright & Co.	Raghuram Selvaraju	PT Cut	Buy	$12→$10
Jun 9, 2025	HC Wainwright & Co.	Raghuram Selvaraju	PT Cut	Buy	$30→$12
May 15, 2025	Canaccord Genuity	Sumant Kulkarni	PT Cut	Buy	$26→$17
Feb 10, 2025	D. Boral Capital	Jason Kolbert	Downgrade	Buy→Hold	—
Nov 11, 2024	D. Boral Capital	Jason Kolbert	Maintained	Buy	$21
Nov 11, 2024	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$30
Oct 25, 2024	Maxim Group	Jason McCarthy	Upgrade	Hold→Buy	$25
Oct 16, 2024	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$30
Oct 15, 2024	EF Hutton	Jason Kolbert	Maintained	Buy	$21
Oct 1, 2024	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$30
Aug 15, 2024	EF Hutton	Jason Kolbert	Maintained	Buy	$21
Aug 15, 2024	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$30
Aug 13, 2024	EF Hutton	Jason Kolbert	Initiate	Buy	$21
Jul 17, 2024	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$30
Jul 11, 2024	HC Wainwright & Co.	Raghuram Selvaraju	PT Raise	Buy	$23→$30

Analyst Ratings News

PRO
Roth Capital Maintains Buy on Annovis Bio, Lowers Price Target to $7

Roth Capital analyst Boobalan Pachaiyappan maintains Annovis Bio (NYSE:ANVS) with a Buy and lowers the price target from $8 to $7.

Benzinga Newsdesk

PRO
Roth Capital Initiates Coverage On Annovis Bio with Buy Rating, Announces Price Target of $8

Roth Capital analyst Boobalan Pachaiyappan initiates coverage on Annovis Bio (NYSE:ANVS) with a Buy rating and announces Price Target of $8.

Benzinga Newsdesk

PRO
Canaccord Genuity Maintains Buy on Annovis Bio, Maintains $17 Price Target

Canaccord Genuity analyst Sumant Kulkarni maintains Annovis Bio (NYSE:ANVS) with a Buy and maintains $17 price target.

Benzinga Newsdesk

Alphabet To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Wednesday

Avi Kapoor

PRO
HC Wainwright & Co. Maintains Buy on Annovis Bio, Lowers Price Target to $10

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Annovis Bio (NYSE:ANVS) with a Buy and lowers the price target from $12 to $10.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Annovis Bio, Lowers Price Target to $12

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Annovis Bio (NYSE:ANVS) with a Buy and lowers the price target from $30 to $12.

Benzinga Newsdesk